Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Surgery Partners (SGRY) Gross Profit (2016 - 2025)

Historic Gross Profit for Surgery Partners (SGRY) over the last 12 years, with Q3 2025 value amounting to $612.6 million.

  • Surgery Partners' Gross Profit rose 766.26% to $612.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.4 billion, marking a year-over-year increase of 1023.54%. This contributed to the annual value of $2.3 billion for FY2024, which is 1516.79% up from last year.
  • According to the latest figures from Q3 2025, Surgery Partners' Gross Profit is $612.6 million, which was up 766.26% from $611.2 million recorded in Q2 2025.
  • In the past 5 years, Surgery Partners' Gross Profit ranged from a high of $641.4 million in Q4 2024 and a low of $365.1 million during Q1 2021
  • For the 5-year period, Surgery Partners' Gross Profit averaged around $500.1 million, with its median value being $494.9 million (2023).
  • In the last 5 years, Surgery Partners' Gross Profit skyrocketed by 4580.5% in 2021 and then surged by 475.08% in 2023.
  • Surgery Partners' Gross Profit (Quarter) stood at $438.7 million in 2021, then increased by 17.55% to $515.7 million in 2022, then grew by 4.75% to $540.2 million in 2023, then rose by 18.73% to $641.4 million in 2024, then decreased by 4.49% to $612.6 million in 2025.
  • Its Gross Profit was $612.6 million in Q3 2025, compared to $611.2 million in Q2 2025 and $560.2 million in Q1 2025.